Margaret Labban
Pricing & Market Access Solutions Manager, Global Pricing Innovations
Dr. Labban has over 17 years of experience leading successful research projects across multiple disciplines from molecular biology, bioinformatics and genetics, to drug pricing data and analytics. Over the past 9 years her areas of interest have focused on pricing and market access within the pharmaceutical sector, including assessment of drug pricing policies and major reforms, and exploration of market access strategies including frameworks to navigate international reference pricing (IRP) rules as well as innovative payment schemes. She has extensive experience working cross-functionally with data scientists, consultants, and health economists on data-driven insights and thought leadership pieces.
As the Pricing & Market Access Solutions specialist at GPI, Dr.Labban is responsible for delivering tailored solutions to address pricing and market access challenges. Prior to joining GPI, she was a Product Manager, working within the commercial team in the Life Sciences business to develop product enhancements, cross-disciplinary projects, and thought leadership.
Dr. Labban holds a doctorate degree in Neuroscience from McGill University, along with a graduate degree in Business Administration from the John Molson School of Business, Canada.